| Posted: February 22, 2009 |
Safer nanoparticles spotlight tumors, deliver drugs |
|
(Nanowerk News) Small is promising when it comes to illuminating tiny tumors or precisely delivering drugs, but many worry about the safety of nano-scale materials. Now a team of scientists has created miniscule flakes of silicon that glow brightly, last long enough to slowly release cancer drugs, then break down into harmless by-products.
|
|
"It is the first luminescent nanoparticle that was purposely designed to minimize toxic side effects," said Michael Sailor, a chemistry professor at the University of California, San Diego who led the study.
|
|
Many nanoparticles tested in research labs are too poisonous for use in humans.
|
|
"This new design meets a growing need for non-toxic alternatives that have a chance to make it into the clinic to treat human patients," Sailor said.
|
 |
| This is a microscopic view of silicon flakes designed to deliver drugs, then dissolve away. (Image: Luo Gu)
|
|
The particles inherently glow, a useful property that is most commonly achieved by including toxic organic chemicals or tiny structures called quantum dots, which can leave potentially harmful heavy metals in their wake.
|
|
When the researchers tested their safer nanoparticles in mice, they saw tumors glow for several hours, then dim as the particles broke down. Levels dropped noticeably in a week and were undetectable after four weeks, they report in Nature Materials February 22.
|
|
This is the first sudy to image tumors and organs using biodegradable silicon nanoparticles in live animals, the authors say.
|
|
The particles begin as thin wafers made porous with an electrical current then smashed to bits with ultrasound. Additional treatment alters the physical structure of the flakes to make them glow red when illuminated with ultraviolet light.
|
|
Luminescent particles can reveal tumors too tiny to detect by other means or allow a surgeon to be sure all of a cancerous growth has been removed.
|
|
These nanoparticles could also help deliver drugs safely, the researchers report. The cancer drug doxorubicin will stick to the pores and slowly escape as the silicon dissolves.
|
|
"The goal is to use the nanoparticles to chaperone the drug directly to the tumor, to release it into the tumor rather than other parts of the body," Sailor said.
|
|
Targeted delivery would allow doctors to use smaller doses of the drug. At doses high enough to be effective, when delivered to the whole body, doxorubicin often has toxic side effects.
|
|
At about 100 nanometers, these particles are bigger than many designed to deliver drugs, which can be just a few nanometers across – a thousand times smaller than the diameter of a human hair.
|
|
Their larger size contributes to both their effectiveness and their safety. Large particles can hold more of a drug. Yet they self-destruct, and the remnants can be filtered away by the kidneys.
|
|
Close examination of vulnerable organs like liver, spleen and kidney, which help to remove toxins, revealed no lasting changes in mice treated with the new nanoparticles.
Features of Sun Dry Swim™
|
|
Breathable 4 way stretch fabric
Fast dry material
Liquids pearl and easily roll off
Long lasting surface protection
|
|
Additional Features of Sun Dry Swim™ Sport
|
|
Extreme Chlorine Resistance
Colorfast in sun, chlorine, sand
Water resistance not affected by UV Rays
|
|
Sun Dry Swim™ and Sun Dry Swim™ Sport bathing suits are available in a selection of men's, ladies and children's fashion, sports and aqua fitness swimming suits. Sizes range from 0-22 for ladies, S -2XL for men, and Children's from 4-16. More styles and colors will be available in the fall through Solestrom.com.
|
|
Sun Dry Technologies was formed in 2005 to fill a niche of providing accessible nanotechnology textile products to consumers. The company offer a wide range of technologically advanced textiles, such as canvas awnings and signs, performance garment fabrics, and vehicle and watercraft textiles. The Sun Dry Swim™ product line can be viewed at www.sundryswim.com.
|
